Next Article in Journal
Effects of a Change from an Indoor-Based Total Mixed Ration to a Rotational Pasture System Combined with a Moderate Concentrate Feed Supply on Immunological Cell and Blood Parameters of Dairy Cows
Next Article in Special Issue
Mycobacterium avium subsp. paratuberculosis ELISA Responses in Milk Samples from Vaccinated and Nonvaccinated Dairy Goat Herds in The Netherlands
Previous Article in Journal
2,4-Thiazolidinedione in Well-Fed Lactating Dairy Goats: I. Effect on Adiposity and Milk Fat Synthesis
Previous Article in Special Issue
Elucidating Transmission Patterns of Endemic Mycobacterium avium subsp. paratuberculosis Using Molecular Epidemiology
 
 
Article
Peer-Review Record

Novel Amphiphilic Cyclobutene and Cyclobutane cis-C18 Fatty Acid Derivatives Inhibit Mycobacterium avium subsp. paratuberculosis Growth

Vet. Sci. 2019, 6(2), 46; https://doi.org/10.3390/vetsci6020046
by Denise K. Zinniel 1, Wantanee Sittiwong 2, Darrell D. Marshall 3, Govardhan Rathnaiah 4, Isin T. Sakallioglu 5, Robert Powers 5,6, Patrick H. Dussault 5 and Raúl G. Barletta 1,*
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Vet. Sci. 2019, 6(2), 46; https://doi.org/10.3390/vetsci6020046
Submission received: 29 April 2019 / Revised: 17 May 2019 / Accepted: 21 May 2019 / Published: 24 May 2019
(This article belongs to the Special Issue Mycobacterial Diseases in Animals)

Round 1

Reviewer 1 Report

The manuscript is well written. The manuscript described the fatty acid derivatives for the treatment of Johne’s disease (JD) caused by Mycobacterium avium subspecies paratuberculosis (Map). The synthetic compounds showed anti-bacteria activity probably due to inhibition of the mycolic acid biosynthetic and/or transport machinery. Thus, These compounds are expected to be promising agents for JD. Therefore, the manuscript is not too excellent to be published. In other words, the manuscript is so excellent that it should be published.

 

Comments

(1) Are synthesized 4-membered ringc fatty acids biologically and chemically stable?

(2) Is cyclobutene moiety synthesized easily? And is it appropriate for drug industry?

(3) The compounds in Table 3 exhibited higher activity against Mtb than Map. Why was it, simply?

(4) What was the inhibitory mechanism of the designed C18 compounds against Map?

(5) Future plan?

 

That is all.


Author Response

please see attached pdf

Author Response File: Author Response.pdf

Reviewer 2 Report

This is an interesting study and makes a useful follow-on (in Map) to the authors' previous work in Mtb. The hypothesis is a very logical one and one that has a great deal of appeal to workers in drug design and discovery in mycobacteria: the uptake of modified fatty acids can result in the inhibition of mycolic acid synthesis---by an as-yet uncharacterized mechanism---and this gives rise to lethality toward mycobacteria. 

On line 255, the authors should punch up the summary. The study gives interesting new material, but it also raises useful new questions. A more thoughtful summary will set off the importance of this work. 

Compounds were prepared as previously done in reference 10.  Although one regrets to see that elemental analyses were not obtained for the compounds in that reference, satisfactory purity was indeed confirmed by other methods; so this is not the venue to quibble about that widespread recent trend away from elemental analysis in compound characterization.   

Author Response

please see attached pdf

Author Response File: Author Response.pdf

Back to TopTop